Rice Hall James & Associates, LLC PROGENICS PHARMACEUTICALS IN Transaction History

Rice Hall James & Associates, LLC

  • $1.53 Billion
  • Q1 2025

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 29, 2020
SELL
N/A
-1,776,490 Closed
0 $0
Q3 2019

Oct 30, 2019
SELL
N/A
-466,013 Reduced 20.78%
1,776,490 $8.98 Million
Q2 2019

Aug 01, 2019
SELL
N/A
-50,676 Reduced 2.21%
2,242,503 $13.8 Million
Q1 2019

May 01, 2019
BUY
N/A
369,680 Added 19.22%
2,293,179 $10.6 Million
Q4 2018

Feb 14, 2019
BUY
N/A
578,239 Added 42.98%
1,923,499 $8.08 Million
Q3 2018

Oct 25, 2018
SELL
N/A
-44,580 Reduced 3.21%
1,345,260 $8.44 Million
Q2 2018

Aug 02, 2018
BUY
N/A
15,378 Added 1.12%
1,389,840 $11.2 Million
Q1 2018

Apr 25, 2018
SELL
N/A
-7,945 Reduced 0.57%
1,374,462 $10.3 Million
Q4 2017

Jan 23, 2018
BUY
N/A
67,464 Added 5.13%
1,382,407 $8.23 Million
Q3 2017

Oct 30, 2017
BUY
N/A
1,314,943
1,314,943 $9.68 Million
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email